115 related articles for article (PubMed ID: 38587184)
1. Survival benefits of human papillomavirus 16 infection in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy: A retrospective cohort study.
Qu F; Ji C; Wang Y; Zhu R; Hu W; Liu S; Zhao X; Li J; Miao G; Zhang M; Zhang X; Sun Y
J Med Virol; 2024 Apr; 96(4):e29592. PubMed ID: 38587184
[TBL] [Abstract][Full Text] [Related]
2. The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers.
Wang WL; Wang YC; Lee CT; Chang CY; Lo JL; Kuo YH; Hsu YC; Mo LR
J Dig Dis; 2015 May; 16(5):256-63. PubMed ID: 25708698
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
Zhang D; Zhang W; Liu W; Mao Y; Fu Z; Liu J; Huang W; Zhang Z; An D; Li B
Radiother Oncol; 2017 Jul; 124(1):155-160. PubMed ID: 28647401
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and p53 mutation in esophageal squamous cell carcinoma and its impact on treatment outcome.
Singh T; Shirazi N; Bansal S; Gupta M; Saini S; Ahmad M
J Cancer Res Ther; 2020 Dec; 16(Supplement):S150-S155. PubMed ID: 33380670
[TBL] [Abstract][Full Text] [Related]
5. Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes.
Zou B; Pang J; Liu Y; Xu Y; Li L; Zhou L; Zhu J; Huang M; Wang J; Ren L; Gong Y; Lu Y; Chen L; Peng F
Thorac Cancer; 2016 Sep; 7(5):515-521. PubMed ID: 27766781
[TBL] [Abstract][Full Text] [Related]
6. Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.
Lian HM; Wu JL; Liufu WJ; Yu TT; Niu SQ; Bao Y; Peng F
Cancer Immunol Immunother; 2024 Feb; 73(3):55. PubMed ID: 38366287
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.
Zhang D; Zhang Q; Zhou L; Huo L; Zhang Y; Shen Z; Zhu Y
BMC Cancer; 2010 Nov; 10():650. PubMed ID: 21108842
[TBL] [Abstract][Full Text] [Related]
8. HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in northern China.
Cao F; Han H; Zhang F; Wang B; Ma W; Wang Y; Sun G; Shi M; Ren Y; Cheng Y
ScientificWorldJournal; 2014; 2014():804738. PubMed ID: 24558329
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Human Papillomavirus Detection in Chagasic Megaesophagus Associated or Not with Esophageal Squamous Cell Carcinoma.
Munari FF; Sichero L; Carloni AC; Lacerda CF; Nunes EM; de Oliveira ATT; Scapulatempo-Neto C; da Silva SRM; Crema E; Adad SJ; Rodrigues MAM; Henry MACA; Guimarães DP; Reis RM; Villa LL; Longatto-Filho A
Pathobiology; 2022; 89(1):29-37. PubMed ID: 34818254
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.
Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H
Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159
[TBL] [Abstract][Full Text] [Related]
11. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
[TBL] [Abstract][Full Text] [Related]
13. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.
Lyu J; Li T; Wang Q; Li F; Diao P; Liu L; Li C; Lang J
Radiat Oncol; 2018 Nov; 13(1):233. PubMed ID: 30477531
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis.
Zhang DH; Chen JY; Hong CQ; Yi DQ; Wang F; Cui W
Cancer; 2014 Sep; 120(17):2673-83. PubMed ID: 24840723
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
Yao B; Tan B; Wang C; Song Q; Wang J; Guan S; Jia Y; Ma Y; Huang X; Sun Y; Cheng Y
Ann Surg Oncol; 2016 Jul; 23(7):2367-72. PubMed ID: 26932711
[TBL] [Abstract][Full Text] [Related]
19. Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
Pao TH; Chen YY; Chang WL; Wu SY; Lai WW; Tseng YL; Chung TJ; Lin FC
PLoS One; 2024; 19(3):e0300173. PubMed ID: 38547184
[TBL] [Abstract][Full Text] [Related]
20. Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients.
Liu A; Wang Y; Wang X; Zhu L; Nie Y; Li M
Radiat Oncol; 2021 Oct; 16(1):195. PubMed ID: 34600574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
